 |
|
|
|
 |
|
|
| Article 1 to 4 out of 4 concerning Varian, Inc.
|
-
Alberta and Varian, Inc. collaborate on disease diagnosis research
(02/01/2006)
Government funds second phase of the Magnetic Resonance Diagnostics Centre
Alberta's Magnetic Resonance Diagnostics Centre at the University of Alberta is getting a boost for continuing collaborative disease diagnosis research using the emerging science of metabolomics. The Alberta government and Varian, Inc. are extending ...
-
Varian, Inc.'s New Focus Solid Phase Extraction Solution Speeds Pharmaceutical Bioanalysis
(09/05/2002)
Simplified extraction of polar compounds from biological matrices; dramatically reduces method development process for drug discovery laboratories
PALO ALTO, Calif., Sep 3, 2002 - Varian, Inc. today introduced its Focus(TM) polar-enhanced Solid Phase Extraction (SPE) product, a solution for extracting developmental pharmaceutical compounds from blood plasma and other biological samples for ...
-
Varian, Inc.'s New LC-NMR-MS System Helps Pharmaceutical Researchers Develop Safer, More Effective Drugs
(04/16/2002)
Instrument Critical for Increasingly Important Field of "Metabonomics"
PALO ALTO, Calif., Varian, Inc. today introduced its LC-NMR-MS system, a new integrated scientific instrument geared for the latest challenges facing drug discovery and development laboratories. Combining three Varian core technologies -- liquid ...
-
Varian, Inc. Introduces Its First BioStandard Used to Validate DHPLC Systems
(04/10/2002)
PALO ALTO, Calif., - Varian, Inc. announced that the company has begun manufacturing biomolecular standards for the first time, as part of its BioSolutions(TM) line of products. The new DYS271 DHPLC Standard is ready-made and designed for easy, ...
|
|
|
|
|
Top
